Atropine 0.05% for rapid progressive childhood myopia

Atropine 0.05% for rapid progressive childhood myopia

Saved in:

Bibliographic Details
Main Author:	Parikshit Gogate
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Indian Journal of Ophthalmology
Online Access:	https://journals.lww.com/10.4103/IJO.IJO_2702_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atropine (0.05%) for rapid progressive childhood myopia (ARM study)
by: Rohit Saxena, et al.
Published: (2025-03-01)

Atropine in Myopia
by: Priyanka Mishra, et al.
Published: (2021-07-01)

Evaluation of Static and Dynamic Pupil and Light Sensitivity to a Single Drop of Various Concentrations of Low-Dose Atropine (0.01%, 0.025%, and 0.05%)
by: Muteb K. Alanazi, et al.
Published: (2025-02-01)

Use of atropine 0.01% eye drops for controlling myopia progression in children
by: Karyna Castro Cárdenas, et al.
Published: (2023-07-01)

Exploring the magnetic and magnetocaloric properties of PLA composite filaments of Mn0.5Fe0.5Ni0.95Cr0.05Si0.95Al0.05 for additive manufacturing
by: Ashika Bhatta, et al.
Published: (2025-03-01)

Effect of Topical Cyclosporine 0.05% in Allergic Conjunctivitis
by: Sonali Bhalla, et al.
Published: (2015-01-01)

Quantitative determination of 0.05 % chlorhexidine solution by capillary electrophoresis
by: A. M. Sampiiev, et al.
Published: (2019-07-01)

Efficient methane production from photocatalytic CO2 reduction by InCu0.05Co0.05Ox: The synergistic effect of Co and Cu
by: Shuhao Li, et al.
Published: (2024-12-01)

Effect of Ga on the Inoxidizability and Wettability of Sn-0.5Ag-0.7Cu-0.05Pr Solder
by: Xu Jiachen, et al.
Published: (2017-01-01)

Amino acids as copper corrosion inhibitors in 0.05M HCl
by: Dragana Medić, et al.
Published: (2015-09-01)

In Vitro Study of Picloxidine 0.05 % Antiviral Activity (on the Example of Adenovirus)
by: G. M. Chernakova, et al.
Published: (2020-11-01)

Comparison of effects of cyclosporine 0.05% and 0.1% in dry eye with Sjögren’s syndrome
by: Donghyun Jee, et al.
Published: (2025-07-01)

Investigation of Firing Conditions and Boron Fluxes for the Optimized Synthesis of LiNi0.9Mn0.05Co0.05O2 for High Energy Density Li‐Ion Batteries
by: Ethan Williams, et al.
Published: (2025-07-01)

Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis
by: Müge Çoban-Karataş, et al.
Published: (2014-08-01)

Evaluation of the efficacy of supplementary probiotic capsules with topical clobetasol propionate 0.05% versus topical clobetasol propionate 0.05% in the treatment of oral lichen planus (a randomized clinical trial)
by: Yasmine Kamal, et al.
Published: (2025-03-01)

A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations
by: Pierluigi Navarra, et al.
Published: (2025-05-01)

Long-term results of orthokeratology correction combined with 0.01 % atropine instilliations in children and adolescents with progressive myopia of various degrees
by: T. Yu. Verzhanskaya
Published: (2023-03-01)

Low-concentration atropine (0.01%) on quantitative contrast sensitivity function in Chinese children with myopia
by: Yu-Hao Ye, et al.
Published: (2025-01-01)

Investigation of the magnetocaloric effect and phase transition in a newly discovered perovskite oxide La0.7Ba0.25Nd0.05Mn1-xZnxO3 for x = 0.03 and 0.05
by: Dey Biswajit, et al.
Published: (2025-01-01)

Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam
by: Sharleen St. Surin-Lord, et al.
Published: (2020-01-01)

Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study
by: Zi-Rong Chen, et al.
Published: (2025-01-01)

Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
by: Zi-Rong Chen, et al.
Published: (2025-01-01)

Experience of amplitude-frequency estimation of ground vibrations in the range of 0,05–0,5 Hz using the sensing element of the GNU-KV gravimeter
by: A. P. Belov, et al.
Published: (2023-06-01)

Dielectric property enhancement and environmental stability in (AlxCr0.05−x)Nb0.05Ti0.9O2 ceramics: influence of Al3+/Cr3+ ratio and Al3+ site preference
by: Porntip Siriya, et al.
Published: (2025-08-01)

The role of atropine in myopia control: insights into choroidal and scleral mechanisms
by: Longxiang Huang, et al.
Published: (2025-03-01)

Formulation of Nystatin 2.4%, Neomycin Sulfate 0.35%, Dexamethasone 0.05% (w/w) Ointment
by: Mohammed J. Mohammed, et al.
Published: (2023-06-01)

Hydrogen-Rich Syngas Production in a Ce<sub>0.9</sub>Zr<sub>0.05</sub>Y<sub>0.05</sub>O<sub>2−δ</sub>/Ag and Molten Carbonates Membrane Reactor
by: José A. Raya-Colín, et al.
Published: (2024-10-01)

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial
by: Sunita Singh, et al.
Published: (2025-05-01)

Enhancement of Photocurrent Stability in Oxidation-Resistant WSe1.95Te0.05 Nanosheets
by: Shiu-Ming Huang, et al.
Published: (2025-06-01)

Cyclosporine (0.05%) Combined with Diclofenac Sodium Eye Drops for the Treatment of Dry Eye Disease
by: Run Bai, et al.
Published: (2022-01-01)

p < 0,05, ¿Criterio mágico para resolver cualquier problema o leyenda urbana?
by: Pedro Monterrey Gutiérrez
Published: (2012-08-01)

Value of adding 0.01% atropine with orthokeratology for myopia in children: an updated meta-analysis of randomized controlled trials
by: Shudan Tu, et al.
Published: (2025-06-01)

EFFECTS OF OZONE TREATMENT ON 0.05% CHLORHEXIDINE BIGLUCONATE SOLUTION: ASSESSMENT OF CRYSTALLOGRAPHY RESULTS IN AN IN VITRO EXPERIMENT
by: V.O. Kurylo, et al.
Published: (2024-07-01)

Thermoelectric Properties of Ca1−xGdxMnO3−δ (0.00, 0.02, and 0.05) Systems
by: Ankam Bhaskar, et al.
Published: (2012-01-01)

Falacias y limitaciones de la significación estadística: ¿qué significa realmente p< 0,05?
by: Ana Belén Salamanca Castro
Published: (2025-06-01)

Results of Observational Study and Integration of Epinastine 0,05% in Treatment Algorythms of Patients with Seasonal Allergic Conjunctivitis
by: D. Yu. Maychuk, et al.
Published: (2024-06-01)

An Experience of Using Cyclosporin 0.05 % (Restasis) in Conjunctival Lymphangiectosia Treatment of Patients With Dry Eye Syndrome
by: S. A. Volik, et al.
Published: (2018-10-01)

0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia
by: Qin Xiang, et al.
Published: (2025-08-01)

Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese
by: Macy M. S. Wu, et al.
Published: (2014-01-01)

Morning Administration is More Effective than Evening Administration of 0.01% Atropine Eye Drops Combined with Orthokeratology for Myopia Control
by: Shuting Xiong, et al.
Published: (2025-08-01)